242 related articles for article (PubMed ID: 20847423)
1. Evidence for participation of aluminum in neurofibrillary tangle formation and growth in Alzheimer's disease.
Walton JR
J Alzheimers Dis; 2010; 22(1):65-72. PubMed ID: 20847423
[TBL] [Abstract][Full Text] [Related]
2. Neurofibrillary pathology and aluminum in Alzheimer's disease.
Shin RW; Lee VM; Trojanowski JQ
Histol Histopathol; 1995 Oct; 10(4):969-78. PubMed ID: 8574016
[TBL] [Abstract][Full Text] [Related]
3. An aluminum-based rat model for Alzheimer's disease exhibits oxidative damage, inhibition of PP2A activity, hyperphosphorylated tau, and granulovacuolar degeneration.
Walton JR
J Inorg Biochem; 2007 Sep; 101(9):1275-84. PubMed ID: 17662457
[TBL] [Abstract][Full Text] [Related]
4. Ultrastructural aspects of neurofibrillary tangle formation in aging and Alzheimer's disease.
Gómez-Ramos P; Morán MA
Microsc Res Tech; 1998 Oct; 43(1):49-58. PubMed ID: 9829459
[TBL] [Abstract][Full Text] [Related]
5. 14-3-3 protein beta isoform is associated with 3-repeat tau neurofibrillary tangles in Alzheimer's disease.
Sugimori K; Kobayashi K; Kitamura T; Sudo S; Koshino Y
Psychiatry Clin Neurosci; 2007 Apr; 61(2):159-67. PubMed ID: 17362433
[TBL] [Abstract][Full Text] [Related]
6. Aluminum in hippocampal neurons from humans with Alzheimer's disease.
Walton JR
Neurotoxicology; 2006 May; 27(3):385-94. PubMed ID: 16458972
[TBL] [Abstract][Full Text] [Related]
7. Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: a laser microprobe (LAMMA) study.
Good PF; Perl DP; Bierer LM; Schmeidler J
Ann Neurol; 1992 Mar; 31(3):286-92. PubMed ID: 1637136
[TBL] [Abstract][Full Text] [Related]
8. Neurofibrillary degeneration in Alzheimer's disease: from molecular mechanisms to identification of drug targets.
Pei JJ; Sjögren M; Winblad B
Curr Opin Psychiatry; 2008 Nov; 21(6):555-61. PubMed ID: 18852562
[TBL] [Abstract][Full Text] [Related]
9. Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils.
Götz J; Chen F; van Dorpe J; Nitsch RM
Science; 2001 Aug; 293(5534):1491-5. PubMed ID: 11520988
[TBL] [Abstract][Full Text] [Related]
10. [Significance of tau in the development of Alzheimer's disease].
Takashima A
Brain Nerve; 2010 Jul; 62(7):701-8. PubMed ID: 20675874
[TBL] [Abstract][Full Text] [Related]
11. Reduction of aggregated Tau in neuronal processes but not in the cell bodies after Abeta42 immunisation in Alzheimer's disease.
Boche D; Donald J; Love S; Harris S; Neal JW; Holmes C; Nicoll JA
Acta Neuropathol; 2010 Jul; 120(1):13-20. PubMed ID: 20532897
[TBL] [Abstract][Full Text] [Related]
12. CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease.
Buerger K; Ewers M; Pirttilä T; Zinkowski R; Alafuzoff I; Teipel SJ; DeBernardis J; Kerkman D; McCulloch C; Soininen H; Hampel H
Brain; 2006 Nov; 129(Pt 11):3035-41. PubMed ID: 17012293
[TBL] [Abstract][Full Text] [Related]
13. Neuron loss from the hippocampus of Alzheimer's disease exceeds extracellular neurofibrillary tangle formation.
Kril JJ; Patel S; Harding AJ; Halliday GM
Acta Neuropathol; 2002 Apr; 103(4):370-6. PubMed ID: 11904757
[TBL] [Abstract][Full Text] [Related]
14. [Neurofibrillary tangles and early modification of the neuronal cytoskeleton in Alzheimer's disease and in experimental models].
Brion JP
Bull Mem Acad R Med Belg; 1999; 154(6 Pt 2):287-94. PubMed ID: 10992876
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls.
Han SH; Hulette C; Saunders AM; Einstein G; Pericak-Vance M; Strittmatter WJ; Roses AD; Schmechel DE
Exp Neurol; 1994 Jul; 128(1):13-26. PubMed ID: 8070517
[TBL] [Abstract][Full Text] [Related]
16. MARKing tau for tangles and toxicity.
Drewes G
Trends Biochem Sci; 2004 Oct; 29(10):548-55. PubMed ID: 15450610
[TBL] [Abstract][Full Text] [Related]
17. Tau in aluminum-induced neurofibrillary tangles.
Singer SM; Chambers CB; Newfry GA; Norlund MA; Muma NA
Neurotoxicology; 1997; 18(1):63-76. PubMed ID: 9215989
[TBL] [Abstract][Full Text] [Related]
18. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
van de Nes JA; Nafe R; Schlote W
Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
[TBL] [Abstract][Full Text] [Related]
19. Tau truncation during neurofibrillary tangle evolution in Alzheimer's disease.
Guillozet-Bongaarts AL; Garcia-Sierra F; Reynolds MR; Horowitz PM; Fu Y; Wang T; Cahill ME; Bigio EH; Berry RW; Binder LI
Neurobiol Aging; 2005 Jul; 26(7):1015-22. PubMed ID: 15748781
[TBL] [Abstract][Full Text] [Related]
20. Phospho-Tau Changes in the Human CA1 During Alzheimer's Disease Progression.
Regalado-Reyes M; Furcila D; Hernández F; Ávila J; DeFelipe J; León-Espinosa G
J Alzheimers Dis; 2019; 69(1):277-288. PubMed ID: 30958368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
